Evidence map›Paper›PMID 40018228›Full record

ArticleBMJ public health2024

How do clinicians use post-COVID syndrome diagnosis? Analysis of clinical features in a Swedish COVID-19 cohort with 18 months' follow-up: a national observational cohort and matched cohort study.

Hanna M Ollila, Osvaldo Fonseca-Rodríguez, Ida Henriette Caspersen, Sebastian Kalucza, Johan Normark, Lill Trogstad, Per Minor Magnus, Naja Hulvej Rod, Andrea Ganna, Marie Eriksson and 1 more

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hanna M OllilaInstitute for Molecular Medicine, FIMM, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-5302-6429
Osvaldo Fonseca-RodríguezDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Ida Henriette CaspersenCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0003-2591-8435
Sebastian KaluczaDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Johan NormarkDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.
Lill TrogstadCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Per Minor MagnusCentre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Naja Hulvej RodDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-6400-5105
Andrea GannaInstitute for Molecular Medicine, FIMM, University of Helsinki, Helsinki, Finland.
Marie ErikssonDepartment of Statistics, Umeå University, Umeå, Sweden.
Anne-Marie Fors ConnollyDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden.ORCID 0000-0001-9215-4047

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: SARS-CoV-2 infection causes acute COVID-19 and may result in post-COVID syndrome (PCS). We aimed to investigate how clinicians diagnose PCS and identify associated clinical and demographic characteristics. Methods: We analysed multiregistry data of all SARS-CoV-2 test-positive individuals in Sweden (n=1 057 174) between 1 February 2020 and 25 May 2021. We described clinical characteristics that prompt PCS diagnosis in outpatient and inpatient settings. In total, there were 6389 individuals with a hospital inpatient or outpatient diagnosis for PCS. To understand symptomatology, we examined individuals diagnosed with PCS at least 3 months after COVID-19 onset (n=6389) and assessed factors associated with PCS diagnosis. Results: Mechanical ventilation correlated with PCS (OR 114.7, 95% CI 105.1 to 125.3) compared with no outpatient/inpatient contact during initial COVID-19. Dyspnoea (13.4%), malaise/fatigue (8%) and abnormal pulmonary diagnostic imaging findings (4.3%) were the most common features linked to PCS. We compared clinical features of PCS with matched controls (COVID-19 negative, n=23 795) and COVID-19 severity-matched patients (COVID-19 positive, n=25 556). Hypertension associated with PCS cohort (26.61%) than in COVID-19-negative (OR 17.16, 95% CI 15.23 to 19.3) and COVID-19-positive (OR 9.25, 95% CI 8.41 to 10.16) controls, although most individuals received this diagnosis before COVID-19. Dyspnoea was the second most common feature in the PCS cohort (17.2%), and new to the majority compared with COVID-19-negative (OR 54.16, 95% CI 42.86 to 68.45) and COVID-19-positive (OR 18.7, 95% CI 16.21 to 21.57) controls. Conclusions: Our findings highlight factors Swedish physicians associate with PCS.

Indexed as

COVID-19epidemiologypublic health

Identifiers

PMID40018228
PMCPMC11816610

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.